This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

Official Name : Scott Gottlieb, M.D., Commissioner of Food and Drugs

Event Date : 10/16/2017 - 10/16/2017
Location : Washington, DC
Subject : National Organization for Rare Disorders: 2017 Rare Diseases and Orphan Products Breakthrough Summit
FDA Participant/Group : KATHLEEN QUINN; ROBERT TEMPLE; PETER MARKS; JEFFREY SHUREN;
Non FDA Participant/Group : Healthcare professionals, academia, industry representatives, media ,and other registered individuals

Event Date : 10/16/2017 - 10/16/2017
Location : Washington, DC
Subject : The National Academy of Medicine President's Forum: The U.S. Opioid Epidemic
FDA Participant/Group : KATHLEEN QUINN;
Non FDA Participant/Group : Healthcare professionals, academia, industry representatives, media, and other registered individuals

Event Date : 10/17/2017 - 10/17/2017
Location : Washington, DC
Subject : National Institute for Health Care Management Foundation Board Meeting
FDA Participant/Group : MAARIKA KIMBRELL;
Non FDA Participant/Group : Several members (National Institute for Health Care Management Foundation );

Event Date : 10/17/2017 - 10/17/2017
Location : Washington, DC
Subject : American Clinical Laboratory Association Board Meeting
FDA Participant/Group : LAUREN SILVIS;
Non FDA Participant/Group : Several members (American Clinical Laboratory Association);

Event Date : 10/19/2017 - 10/19/2017
Location : Baltimore, MD
Subject : The U.S. Food and Drug Administration's Framework: Nicotine Regulation
FDA Participant/Group : MITCHELL ZELLER; MICHAEL FELBERBAUM;
Non FDA Participant/Group : Several faculty, students, and staff (Johns Hopkins Bloomberg School of Public Health );

Event Date : 10/20/2017 - 10/20/2017
Location : Silver Spring, MD
Subject : Recent Developments Related to Antibiotic Development and Diagnostics
FDA Participant/Group : CARA TENENBAUM; MAARIKA KIMBRELL; STEVEN GITTERMAN; LAUREN SILVIS; PETER MARKS; SUMATHI NAMBIAR; EDWARD COX; KATHLEEN QUINN; ELIZABETH HILLEBRENNER; JOSEPHINE TROPEA; JEFFREY SHUREN; KATHERINE SCHUMANN;
Non FDA Participant/Group : Helen Boucher; Kimberly Hanson; Amanda Jezek; Jaclyn Levy (Infectious Diseases Society of America); Sue Ramthun (Hart Health Strategies);

Official Name : Rachel Sherman, M.D., M.P.H.,, Principal Deputy Commissioner

No Significant Event

Official Name : Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis

No Significant Event

Official Name : Dara Corrigan, Acting Deputy Commissioner for Global Regulatory Operations and Policy

No Significant Event

Official Name : Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name : Stephen M. Ostroff, M.D., Deputy Commissioner for Foods and Veterinary Medicine

Event Date : 10/19/2017
Location : Marana, AZ
Subject : Council for Responsible Nutrition: FDA Priorities for Dietary Supplements & Functional Food
FDA Participant/Group : N/A
Non FDA Participant/Group : Several members (Council for Responsible Nutrition);

Official Name : Melinda Plaisier, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name : Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name : Jack Kalavritinos, Associate Commissioner for External Affairs

No Significant Event

Official Name : CAPT Denise Hinton, Acting Chief Scientist

No Significant Event

Official Name : Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name : Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date : 10/17/2017 - 10/17/2017
Location : Washington, DC
Subject : National Organization for Rare Disorders 2017 Rare Diseases and Orphan Products Breakthrough Summit: Advancing Products for Rare Diseases
FDA Participant/Group : JEFFREY SHUREN;Several FDA officials and staff members
Non FDA Participant/Group : N/A

Official Name : Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date : 10/17/2017 - 10/17/2017
Location : Washington, DC
Subject : National Organization for Rare Disorders 2017 Rare Diseases and Orphan Products Breakthrough Summit: Rare Disease Drug, Biologic and Device Development: Achievements and Opportunities
FDA Participant/Group : PETER MARKS;Several FDA officials and staff members
Non FDA Participant/Group : N/A

Official Name : Susan T. Mayne Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name : Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name : Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name : William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name : Rebecca K. Wood, J.D., Chief Counsel

No Significant Event